Integrating clinical-molecular data to predict PARP inhibitors efficacy in advanced ovarian cancer patients after interval cytoreductive surgery

Update your browser to view ScienceDirect correctly.

Your technical details and browser version:

Request ID: 921e0bd9fc4b67f9-LAX IP: 118.31.43.22 UTC time: 2025-03-17T17:00:24+00:00 Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4